Semra Ince, Richard Laforest, Malak Itani, Vikas Prasad, Paul-Robert Derenoncourt, John P Crandall, Saeed Ashrafinia, Anne M Smith, Richard L Wahl, Tyler J Fraum
{"title":"普通肿瘤 PET/CT 群体中肿瘤活性的定量评估:哪种指标能将示踪剂摄取时间依赖性降至最低?","authors":"Semra Ince, Richard Laforest, Malak Itani, Vikas Prasad, Paul-Robert Derenoncourt, John P Crandall, Saeed Ashrafinia, Anne M Smith, Richard L Wahl, Tyler J Fraum","doi":"10.2967/jnumed.123.266469","DOIUrl":null,"url":null,"abstract":"<p><p>In oncologic PET, the SUV and standardized uptake ratio (SUR) of a viable tumor generally increase during the postinjection period. In contrast, the net influx rate (<i>K<sub>i</sub></i> ), which is derived from dynamic PET data, should remain relatively constant. Uptake-time-corrected SUV (cSUV) and SUR (cSUR) have been proposed as uptake-time-independent, static alternatives to <i>K<sub>i</sub></i> Our primary aim was to quantify the intrascan repeatability of <i>K<sub>i</sub></i> , SUV, cSUV, SUR, and cSUR among malignant lesions on PET/CT. An exploratory aim was to assess the ability of cSUR to estimate <i>K<sub>i</sub></i> <b>Methods:</b> This prospective, single-center study enrolled adults undergoing standard-of-care oncologic PET/CT. SUV and <i>K<sub>i</sub></i> images were reconstructed from dynamic PET data obtained before (∼35-50 min after injection) and after (∼75-90 min after injection) standard-of-care imaging. Tumors were manually segmented. Quantitative metrics were extracted. cSUVs and cSURs were calculated for a 60-min postinjection reference uptake time. The magnitude of the intrascan test-retest percent change (test-retest |%Δ|) was calculated. Coefficients of determination (<i>R</i> <sup>2</sup>) and intraclass correlation coefficients (ICC) were also computed. Differences between metrics were assessed via the Wilcoxon signed-rank test (α, 0.05). <b>Results:</b> This study enrolled 78 subjects; 41 subjects (mean age, 63.8 y; 24 men) with 116 lesions were analyzed. For both tracers, SUV<sub>max</sub> and maximum SUR (SUR<sub>max</sub>) had large early-to-late increases (i.e., poor intrascan repeatability). Among [<sup>18</sup>F]FDG-avid lesions (<i>n</i> = 93), there were no differences in intrascan repeatability (median test-retest |%Δ|; ICC) between the maximum <i>K<sub>i</sub></i> (<i>K<sub>i</sub></i> <sub>,max</sub>) (13%; 0.97) and either the maximum cSUV (cSUV<sub>max</sub>) (12%, <i>P</i> = 0.90; 0.96) or the maximum cSUR (cSUR<sub>max</sub>) (13%, <i>P</i> = 0.67; 0.94). For DOTATATE-avid lesions (<i>n</i> = 23), there were no differences in intrascan repeatability between the <i>K<sub>i</sub></i> <sub>,max</sub> (11%; 0.98) and either the cSUV<sub>max</sub> (13%, <i>P</i> = 0.41; 0.98) or the cSUR<sub>max</sub> (11%, <i>P</i> = 0.08; 0.94). The SUV<sub>max</sub>, cSUV<sub>max</sub>, SUR<sub>max</sub>, and cSUR<sub>max</sub> were all strongly correlated with the <i>K<sub>i</sub></i> <sub>,max</sub> for both [<sup>18</sup>F]FDG (<i>R</i> <sup>2</sup>, 0.81-0.92) and DOTATATE (<i>R</i> <sup>2</sup>, 0.88-0.96), but the cSUR<sub>max</sub> provided the best agreement with the <i>K<sub>i</sub></i> <sub>,max</sub> across early-to-late time points for [<sup>18</sup>F]FDG (ICC, 0.69-0.75) and DOTATATE (ICC, 0.90-0.91). <b>Conclusion:</b> <i>K<sub>i</sub></i> <sub>,max</sub>, cSUV<sub>max</sub>, and cSUR<sub>max</sub> had low uptake time dependence compared with SUV<sub>max</sub> and SUR<sub>max</sub> The <i>K<sub>i</sub></i> <sub>,max</sub> can be predicted from cSUR<sub>max</sub>.</p>","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1349-1356"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372261/pdf/","citationCount":"0","resultStr":"{\"title\":\"Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?\",\"authors\":\"Semra Ince, Richard Laforest, Malak Itani, Vikas Prasad, Paul-Robert Derenoncourt, John P Crandall, Saeed Ashrafinia, Anne M Smith, Richard L Wahl, Tyler J Fraum\",\"doi\":\"10.2967/jnumed.123.266469\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In oncologic PET, the SUV and standardized uptake ratio (SUR) of a viable tumor generally increase during the postinjection period. In contrast, the net influx rate (<i>K<sub>i</sub></i> ), which is derived from dynamic PET data, should remain relatively constant. Uptake-time-corrected SUV (cSUV) and SUR (cSUR) have been proposed as uptake-time-independent, static alternatives to <i>K<sub>i</sub></i> Our primary aim was to quantify the intrascan repeatability of <i>K<sub>i</sub></i> , SUV, cSUV, SUR, and cSUR among malignant lesions on PET/CT. An exploratory aim was to assess the ability of cSUR to estimate <i>K<sub>i</sub></i> <b>Methods:</b> This prospective, single-center study enrolled adults undergoing standard-of-care oncologic PET/CT. SUV and <i>K<sub>i</sub></i> images were reconstructed from dynamic PET data obtained before (∼35-50 min after injection) and after (∼75-90 min after injection) standard-of-care imaging. Tumors were manually segmented. Quantitative metrics were extracted. cSUVs and cSURs were calculated for a 60-min postinjection reference uptake time. The magnitude of the intrascan test-retest percent change (test-retest |%Δ|) was calculated. Coefficients of determination (<i>R</i> <sup>2</sup>) and intraclass correlation coefficients (ICC) were also computed. Differences between metrics were assessed via the Wilcoxon signed-rank test (α, 0.05). <b>Results:</b> This study enrolled 78 subjects; 41 subjects (mean age, 63.8 y; 24 men) with 116 lesions were analyzed. For both tracers, SUV<sub>max</sub> and maximum SUR (SUR<sub>max</sub>) had large early-to-late increases (i.e., poor intrascan repeatability). Among [<sup>18</sup>F]FDG-avid lesions (<i>n</i> = 93), there were no differences in intrascan repeatability (median test-retest |%Δ|; ICC) between the maximum <i>K<sub>i</sub></i> (<i>K<sub>i</sub></i> <sub>,max</sub>) (13%; 0.97) and either the maximum cSUV (cSUV<sub>max</sub>) (12%, <i>P</i> = 0.90; 0.96) or the maximum cSUR (cSUR<sub>max</sub>) (13%, <i>P</i> = 0.67; 0.94). For DOTATATE-avid lesions (<i>n</i> = 23), there were no differences in intrascan repeatability between the <i>K<sub>i</sub></i> <sub>,max</sub> (11%; 0.98) and either the cSUV<sub>max</sub> (13%, <i>P</i> = 0.41; 0.98) or the cSUR<sub>max</sub> (11%, <i>P</i> = 0.08; 0.94). The SUV<sub>max</sub>, cSUV<sub>max</sub>, SUR<sub>max</sub>, and cSUR<sub>max</sub> were all strongly correlated with the <i>K<sub>i</sub></i> <sub>,max</sub> for both [<sup>18</sup>F]FDG (<i>R</i> <sup>2</sup>, 0.81-0.92) and DOTATATE (<i>R</i> <sup>2</sup>, 0.88-0.96), but the cSUR<sub>max</sub> provided the best agreement with the <i>K<sub>i</sub></i> <sub>,max</sub> across early-to-late time points for [<sup>18</sup>F]FDG (ICC, 0.69-0.75) and DOTATATE (ICC, 0.90-0.91). <b>Conclusion:</b> <i>K<sub>i</sub></i> <sub>,max</sub>, cSUV<sub>max</sub>, and cSUR<sub>max</sub> had low uptake time dependence compared with SUV<sub>max</sub> and SUR<sub>max</sub> The <i>K<sub>i</sub></i> <sub>,max</sub> can be predicted from cSUR<sub>max</sub>.</p>\",\"PeriodicalId\":94099,\"journal\":{\"name\":\"Journal of nuclear medicine : official publication, Society of Nuclear Medicine\",\"volume\":\" \",\"pages\":\"1349-1356\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372261/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of nuclear medicine : official publication, Society of Nuclear Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2967/jnumed.123.266469\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2967/jnumed.123.266469","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在肿瘤正电子发射计算机断层显像中,有活力肿瘤的 SUV 和标准化摄取比(SUR)通常在注射后期间增加。相比之下,根据动态 PET 数据得出的净流入率(Ki)应保持相对恒定。我们的主要目的是量化 PET/CT 恶性病变中 Ki、SUV、cSUV、SUR 和 cSUR 的扫描内重复性。探索性目的是评估 cSUR 估算 Ki 的能力:这项前瞻性单中心研究招募了接受标准治疗肿瘤 PET/CT 的成人。根据标准治疗成像前(注射后 35-50 分钟)和成像后(注射后 75-90 分钟)获得的动态 PET 数据重建 SUV 和 Ki 图像。对肿瘤进行人工分割。以注射后 60 分钟为参考摄取时间,计算 cSUV 和 cSUR。计算扫描内测试-重测百分比变化(测试-重测 |%Δ|)的幅度。还计算了测定系数(R 2)和类内相关系数(ICC)。指标之间的差异通过 Wilcoxon 符号秩检验进行评估(α,0.05)。结果本研究共纳入 78 名受试者,对 41 名受试者(平均年龄 63.8 岁;男性 24 名)的 116 个病灶进行了分析。两种示踪剂的 SUVmax 和最大 SUR(SURmax)在早期到晚期都有较大的增长(即级内重复性较差)。在[18F]FDG-avid病变(n = 93)中,最大Ki (Ki ,max) (13%; 0.97)和最大cSUV (cSUVmax) (12%, P = 0.90; 0.96)或最大cSUR (cSURmax) (13%, P = 0.67; 0.94)之间的级内重复性(中位数测试-重复测试|%Δ|;ICC)没有差异。对于 DOTATATE-avid 病变(n = 23),Ki ,max (11%; 0.98) 与 cSUVmax (13%, P = 0.41; 0.98) 或 cSURmax (11%, P = 0.08; 0.94) 之间的扫描内重复性没有差异。SUVmax、cSUVmax、SURmax和cSURmax均与[18F]FDG(R 2,0.81-0.92)和DOTATATE(R 2,0.88-0.96)的Ki ,max密切相关,但cSURmax与[18F]FDG(ICC,0.69-0.75)和DOTATATE(ICC,0.90-0.91)从早到晚各时间点的Ki ,max的一致性最好。结论与 SUVmax 和 SURmax 相比,Ki ,max、cSUVmax 和 cSURmax 的摄取时间依赖性较低。
Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?
In oncologic PET, the SUV and standardized uptake ratio (SUR) of a viable tumor generally increase during the postinjection period. In contrast, the net influx rate (Ki ), which is derived from dynamic PET data, should remain relatively constant. Uptake-time-corrected SUV (cSUV) and SUR (cSUR) have been proposed as uptake-time-independent, static alternatives to Ki Our primary aim was to quantify the intrascan repeatability of Ki , SUV, cSUV, SUR, and cSUR among malignant lesions on PET/CT. An exploratory aim was to assess the ability of cSUR to estimate KiMethods: This prospective, single-center study enrolled adults undergoing standard-of-care oncologic PET/CT. SUV and Ki images were reconstructed from dynamic PET data obtained before (∼35-50 min after injection) and after (∼75-90 min after injection) standard-of-care imaging. Tumors were manually segmented. Quantitative metrics were extracted. cSUVs and cSURs were calculated for a 60-min postinjection reference uptake time. The magnitude of the intrascan test-retest percent change (test-retest |%Δ|) was calculated. Coefficients of determination (R2) and intraclass correlation coefficients (ICC) were also computed. Differences between metrics were assessed via the Wilcoxon signed-rank test (α, 0.05). Results: This study enrolled 78 subjects; 41 subjects (mean age, 63.8 y; 24 men) with 116 lesions were analyzed. For both tracers, SUVmax and maximum SUR (SURmax) had large early-to-late increases (i.e., poor intrascan repeatability). Among [18F]FDG-avid lesions (n = 93), there were no differences in intrascan repeatability (median test-retest |%Δ|; ICC) between the maximum Ki (Ki,max) (13%; 0.97) and either the maximum cSUV (cSUVmax) (12%, P = 0.90; 0.96) or the maximum cSUR (cSURmax) (13%, P = 0.67; 0.94). For DOTATATE-avid lesions (n = 23), there were no differences in intrascan repeatability between the Ki,max (11%; 0.98) and either the cSUVmax (13%, P = 0.41; 0.98) or the cSURmax (11%, P = 0.08; 0.94). The SUVmax, cSUVmax, SURmax, and cSURmax were all strongly correlated with the Ki,max for both [18F]FDG (R2, 0.81-0.92) and DOTATATE (R2, 0.88-0.96), but the cSURmax provided the best agreement with the Ki,max across early-to-late time points for [18F]FDG (ICC, 0.69-0.75) and DOTATATE (ICC, 0.90-0.91). Conclusion:Ki,max, cSUVmax, and cSURmax had low uptake time dependence compared with SUVmax and SURmax The Ki,max can be predicted from cSURmax.